Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...

ACE inhibitor benefit for vascular events and heart failure prevention is firmly established for many coronary artery disease patients; the PEACE findings should not change practice for the ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...

ACE-I = Angiotensin converting enzyme inhibitor; ARB = Angiotensin receptor blocker; BB = β-blocker; BP = Blood pressure; HF = Heart failure; I/H = Isosorbide dinitrate/hydralazine; JNC = Joint ...

The FDA has accepted for review the BLA for lerodalcibep to reduce LDL-C in patients with or high risk of ASCVD and primary hyperlipidemia.

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.

Cough and angioedema are well-known adverse reactions of ACE inhibitors. However, other adverse effects of upper airways such as postnasal drainage, rhinitis and nasal blockage, are less frequently ...

They wanted to find out if the most commonly used blood pressure medication, called ACE inhibitors ... sugar could help reduce blood pressure and artery stiffness. For more information about ...

Data are not imputed for death except neuroscore. The scale bar shows 2 mm. CCAO indicates common carotid artery occlusion; IαIP, inter‐α inhibitor proteins; tMCAO, transient middle cerebral artery ...